Color Flow Doppler Ultrasound in Subclinical Thyroid Dysfunction
NCT ID: NCT00437931
Last Updated: 2016-09-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2007-02-28
2008-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lipids Profile in Subclinical Hypothyroidism
NCT00962221
Thyroid Profiles in Patients With Acute Illness
NCT05980923
The Impact of Subclinical Hypothyroidism on Cardiovascular System
NCT04236232
Subclinical Thyroid Dysfunction and Risk of Myocardial Infarction and Stroke
NCT00094237
Color Doppler Analysıs Of Uterin And Intraovarian Blood Flow Before And After Treatment Wıth Cabergoline In Hyperprolactinemic Patients
NCT01957839
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
patients with subclinical hypothyroidism
No interventions assigned to this group
B
patients with subclinical hyperthyroidism
No interventions assigned to this group
C
patient with normal thyroid function.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with thyroid nodules and normal thyroid function
Exclusion Criteria
* patients who had thyroid surgery or radioiodine therapy
* patients with NYHA class 3 or 4 heart failure
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HaEmek Medical Center, Israel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
avraham ishay
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Avraham Ishay, MD
Role: PRINCIPAL_INVESTIGATOR
Haemek Medical Center, Endocrine Institute, Afula, Israel
Leonid Chervinsky
Role: STUDY_CHAIR
Haemek Medical Center, Department of Radiology, Afula , Israel
Rafael Luboshitzky, MD
Role: STUDY_CHAIR
Haemek Medical Center, Endocrine Institute, Afula, Israel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haemek Medical Center, Department of Radiology
Afula, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
006-07-EMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.